![](/img/cover-not-exists.png)
Does adjuvant interferon-α for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials
Keith Wheatley, Natalie Ives, Barry Hancock, Martin Gore, Alexander Eggermont, Stefan SuciuVolume:
29
Year:
2003
Language:
english
DOI:
10.1016/s0305-7372(03)00074-4
File:
PDF, 226 KB
english, 2003